Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

Physicians (Mostly) Negative on Private Equity in Healthcare

Michael O'Riordan

March 13, 2024

News Daily News

FDA Advisors Unconvinced by Lutonix BTK Drug-Coated Balloon

L.A. McKeown

February 18, 2021

News Conference News ACC 2020

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

L.A. McKeown

April 02, 2020

News Daily News

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

L.A. McKeown

June 20, 2019

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Conference News VIVA 2017

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

L.A. McKeown

September 13, 2017

News Industry News

Neuravi Announces Completion of Patient Enrollment in Clinical Trial of a Novel Stent Retriever for Acute Ischemic Stroke

February 21, 2017

News Daily News

Conflicting Results: Personal Financial Ties Among Investigators Linked to Positive Trial Findings

Shelley Wood

January 19, 2017

News Daily News

Questions Over Risk-Benefit Balance for IVC Filters Still Vex Clinicians

Caitlin E. Cox

November 17, 2016

News Daily News

Las Dudas en torno al Equilibrio Riesgos-Beneficios para los Filtros VCI Siguen Irritando a los Médicos

Caitlin E. Cox

November 17, 2016

News Conference News VIVA 2016

IVUS Improves Management of Iliofemoral Venous Stenting

L.A. McKeown

September 20, 2016

News Daily News

Según una Revisión las Evidencias que Avalan la Exclusión Percutánea o Quirúrgica del AAI para la Prevención de ACV son Limitadas

Todd Neale

July 14, 2016

News Daily News

Evidence Supporting Percutaneous or Surgical LAA Exclusion for Stroke Prevention Is Limited, Review Says

Todd Neale

July 14, 2016

News Daily News

Even When It Fails, Endovascular Therapy Better First-Line Treatment than Surgery for Aortoiliac Disease

L.A. McKeown

September 19, 2012

News Daily News

Aún Cuando Fracasa, la Terapia Endovascular es Mejor como Tratamiento de 1ª Línea que la Cirugía contra la Enfermedad Aortoilíaca

L.A. McKeown

September 19, 2012

Advertisement

Physicians (Mostly) Negative on Private Equity in Healthcare

FDA Advisors Unconvinced by Lutonix BTK Drug-Coated Balloon

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

Neuravi Announces Completion of Patient Enrollment in Clinical Trial of a Novel Stent Retriever for Acute Ischemic Stroke

Conflicting Results: Personal Financial Ties Among Investigators Linked to Positive Trial Findings

Questions Over Risk-Benefit Balance for IVC Filters Still Vex Clinicians

Las Dudas en torno al Equilibrio Riesgos-Beneficios para los Filtros VCI Siguen Irritando a los Médicos

IVUS Improves Management of Iliofemoral Venous Stenting

Según una Revisión las Evidencias que Avalan la Exclusión Percutánea o Quirúrgica del AAI para la Prevención de ACV son Limitadas

Evidence Supporting Percutaneous or Surgical LAA Exclusion for Stroke Prevention Is Limited, Review Says

Even When It Fails, Endovascular Therapy Better First-Line Treatment than Surgery for Aortoiliac Disease

Aún Cuando Fracasa, la Terapia Endovascular es Mejor como Tratamiento de 1ª Línea que la Cirugía contra la Enfermedad Aortoilíaca

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content